The global nanocapsules market size is estimated to register a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the enhanced facilities for disease treatment, targeted deliveries, and rising incidence of chronic diseases.
Nanocapsule refers to the extraction of nanoscale shell made from non-toxic polymer. These capsules have an inner desired liquid core at the nanoscale. This facilitates intensified delivery of bio-active molecules for targeted delivery. Some of the uses of nanocapsules are for self-healing materials including food enhancement, nutraceuticals, and promising medical applications for drug delivery.
Increasing incidence of chronic diseases globally have pushed to raise the demand for effective and novel drug delivery systems that can allow delivering the desired amount of drugs on the specific area at a given time. Cosmetics, food, healthcare, and agriculture industries among others constitute the major operating areas of nanocapsules.
Continuous research and development projects in the nanotechnology field is expected to help the market growth and provide a bunch of opportunities for various industries. These capsules deliver active ingredients at target areas, which forms one of the important advantages of nanocapsules. Rapid oxidation and pyrophoric properties provide other advantages. These properties present various challenges and opportunities for the development and commercialization of novel and improved therapies. The COVID-19 situation has largely impacted this industry as all the manufacturing firms and all the non-urgent outlets were shut down due to lockdown restrictions.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing number of patients suffering from chronic diseases globally is a key driver of the market.
- Wide engagement such as R&D activities for the development of effective and novel drug delivery systems are expected to boost the market growth in the coming years.
- Nanocapsules provide effective results while avoiding side effects. This has scaled up the adoption rate of the products among patients. This is a key driving factor of the market.
- Rapid advancement of new technology in the field of nano science is expected to provide a plethora of opportunities for the market expansion.
- Growing investments by several companies in research and commercialization of drug development activities are further expected to boost the market growth during the projected period.
Scope of Nanocapsules Market Report
The report on the global nanocapsules market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Nanocapsules Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Applications (Cosmetics, Food & Nutraceuticals, Healthcare, Agricultural Production, and Others) and Therapy Areas (Pain Management, Oncology, Endocrinology, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
BioDelivery Sciences International, Inc.; Camurus ABCARLINA Technologies S.A.S.; Cerulean Pharma Inc.; NanoNutra; NanoSphere Health Sciences Inc.; and L’Oreal S.A.
|
Nanocapsules Market Segment Insights
Healthcare segment is expected to grow at a rapid pace
Based on applications, the global nanocapsules market is divided into cosmetics, food & nutraceuticals, healthcare, agricultural production, and others. The healthcare segment accounted for a key share of the market in 2019 and is expected to grow at a rapid pace owing to increased funding by developed countries for finding potential applications of nanocapsules in healthcare and medical areas. However, the food & nutraceuticals segment is anticipated to expand at a healthy growth rate during the forecast period due to wide application of the advanced nanotechnology in food processing methods.
Oncology segment is projected to expand at a considerable CAGR
On the basis of therapy areas, the market is divided into pain management, oncology, endocrinology, and others. The oncology segment is projected to expand at a considerable CAGR during the forecast period owing to increasing cancer incidences globally and wide research activities to develop new methods for cancer treatment. Meanwhile, the endocrinology segment is anticipated to grow significantly during the forecast period due to unmet medical needs and demand for accurate cure of the methods.
North America is anticipated to constitute a key market share
In terms of regions, the global nanocapsules market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America accounted for a key share of the market in 2019 and is anticipated to constitute a large market share during the targeted period owing to increasing investments and research by developed countries in technology advancement. The market of Asia Pacific, however, is anticipated to register a substantial growth rate during the forecast period due to increasing opportunities for life science in the region.
Segments
The global nanocapsules market has been segmented on the basis of
Applications
- Cosmetics
- Food & Nutraceuticals
- Healthcare
- Agricultural Production
- Others
Therapy Areas
- Pain Management
- Oncology
- Endocrinology
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- BioDelivery Sciences International, Inc.
- Camurus ABCARLINA Technologies S.A.S.
- Cerulean Pharma Inc.
- NanoNutra
- NanoSphere Health Sciences Inc.
- L’Oreal S.A.
Competitive Landscape
Key players competing in the global nanocapsules market are BioDelivery Sciences International, Inc.; Camurus ABCARLINA Technologies S.A.S.; Cerulean Pharma Inc.; NanoNutra; NanoSphere Health Sciences Inc.; and L’Oreal S.A. The main market players are continuously engaged in various business expansion activities such as mergers and acquisitions, research and developments, investments for innovative products, and collaborations to enhance its market position. For instance, Novartis, in a partnership with Camurus, is developing a product (CAM 2029) and is in phase II trial.
Request For Customization
Enquiry Before Buying
Speak With Analyst
